Research Articles
Research articles concerning CKD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in CKDdb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Diabetes mellitus148 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A00135 | 20651284 | Circ Res | Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. | 2010 | Details |
A00137 | 21186350 | Nat Genet | Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes. | 2011 | Details |
A00138 | 21364139 | JAMA | Functional variants of the HMGA1 gene and type 2 diabetes mellitus. | 2011 | Details |
A00140 | 21673050 | Genome Res | Alterations in TCF7L2 expression define its role as a key regulator of glucose metabolism. | 2012 | Details |
A00141 | 22286214 | Nat Genet | Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes. | 2012 | Details |
A00144 | 24193408 | Pflugers Arch | Polycystin-1 but not polycystin-2 deficiency causes upregulation of the mTOR pathway and can be synergistically targeted with rapamycin and metformin. | 2015 | Details |
A00145 | 24390345 | Nature | Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico. | 2014 | Details |
A00146 | 24463454 | J Clin Invest | Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients. | 2014 | Details |
A00149 | 24897035 | Kidney Int | The HNF1B score is a simple tool to select patients for HNF1B gene analysis. | 2015 | Details |
A00150 | 24904092 | J Am Soc Nephrol | Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials. | 2015 | Details |
A00152 | 25349199 | J Am Soc Nephrol | A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome. | 2015 | Details |
A00153 | 25536396 | Nat Rev Nephrol | HNF1B-associated renal and extra-renal disease-an expanding clinical spectrum. | 2015 | Details |
A00156 | 25786098 | Kidney Int | Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. | 2016 | Details |
A00157 | 25894829 | Nat Med | Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion. | 2015 | Details |
A00160 | 26551672 | Nat Genet | Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci. | 2016 | Details |
A00162 | 2695375 | Diabetes | Distribution of in vivo insulin action in Pima Indians as mixture of three normal distributions. | 1990 | Details |
A00163 | 27188453 | Eur J Endocrinol | Clinical and genetic characterization of congenital hyperinsulinism in Spain. | 2017 | Details |
A00164 | 27398621 | Nature | The genetic architecture of type 2 diabetes. | 2016 | Details |
A00165 | 27484667 | Nephrol Dial Transplant | Prognostic enrichment design in clinical trials for autosomal dominant polycystic kidney disease: the HALT-PKD clinical trial. | 2018 | Details |
A00167 | 27896077 | Mol Genet Metab Rep | Sequencing analysis of insulin receptor defects and detection of two novel mutations in <i>INSR</i> gene. | 2020 | Details |
A00168 | 27908292 | Orphanet J Rare Dis | Conservatively treated Congenital Hyperinsulinism (CHI) due to K-ATP channel gene mutations: reducing severity over time. | 2017 | Details |
A00171 | 28838955 | J Am Soc Nephrol | Bosutinib versus Placebo for Autosomal Dominant Polycystic Kidney Disease. | 2017 | Details |
A00172 | 29361385 | J Formos Med Assoc | Mutation screening of INS and KCNJ11 genes in Taiwanese children with type 1B diabetic onset before the age of 5 years. | 2018 | Details |
A00174 | 29471960 | Nefrologia (Engl Ed) | Overview of autosomal dominant polycystic kidney disease in the south of Spain. | 2018 | Details |
A00175 | 29674338 | Clin J Am Soc Nephrol | Prevalence of Hypertension in Children with Early-Stage ADPKD. | 2019 | Details |
A00176 | 29751826 | BMC Med Genet | Possible association between ABCC8 C49620T polymorphism and type 2 diabetes in a Nigerian population. | 2019 | Details |
A00177 | 30422235 | JAMA | Effect of Lanreotide on Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease: The DIPAK 1 Randomized Clinical Trial. | 2018 | Details |
A00178 | 30927425 | Hum Reprod | Factors influencing the clinical outcome of preimplantation genetic testing for polycystic kidney disease. | 2020 | Details |
A00185 | 32634120 | JCI Insight | The value of genotypic and imaging information to predict functional and structural outcomes in ADPKD. | 2021 | Details |
A00186 | 32939031 | Genet Med | Clinical impact of genomic testing in patients with suspected monogenic kidney disease. | 2021 | Details |
A00187 | 33097957 | Nephrol Dial Transplant | Mutations in transcription factor CP2-like 1 may cause a novel syndrome with distal renal tubulopathy in humans. | 2021 | Details |
A00188 | 33141305 | Clin Exp Nephrol | Effect of tolvaptan on renal involvement in patients with autosomal dominant polycystic kidney disease according to different gene mutations. | 2021 | Details |
A00189 | 33164752 | Elife | The heteromeric PC-1/PC-2 polycystin complex is activated by the PC-1 N-terminus. | 2021 | Details |
A00191 | 33853507 | Nucleosides Nucleotides Nucleic Acids | Association of common genetic variants of <i>KCNJ11</i> gene with the risk of type 2 diabetes mellitus. | 2024 | Details |
A00192 | 34145744 | Am J Med Genet A | Homozygous WNT9B variants in two families with bilateral renal agenesis/hypoplasia/dysplasia. | 2022 | Details |
A00193 | 36646975 | Pediatr Nephrol | Dual diagnosis of autosomal dominant polycystic kidney disease and sickle cell disease in a teenage male. | 2023 | Details |
A00194 | 39660790 | J Med Econ | Cost-effectiveness analysis of radiofrequency renal denervation for uncontrolled hypertension in Canada. | 2024 | Details |
A00195 | 39684653 | Int J Mol Sci | Pharmacological Nephroprotection in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus-Clinical Practice Position Statement of the Polish Society of Nephrology. | 2024 | Details |
A00196 | 39704168 | JCI Insight | Fasting substrates predict chronic kidney disease progression in CREDENCE trial patients with type 2 diabetes. | 2024 | Details |
A00197 | 39731488 | Malays J Pathol | MACB CKD Task Force updated recommendations for reporting estimated glomerular filtration rate and albuminuria in adults. | 2024 | Details |
A00198 | 39746795 | Ren Fail | Dapagliflozin improves diabetic kidney disease by inhibiting ferroptosis through β-hydroxybutyrate production. | 2025 | Details |
A00199 | 39783822 | J Med Econ | Cost-effectiveness of finerenone therapy for patients with chronic kidney disease and type 2 diabetes in England & Wales: results of the FINE-CKD model. | 2025 | Details |
A00200 | 39804512 | Langenbecks Arch Surg | A hypocaloric protein-rich diet before metabolic surgery improves liver function in patients with obesity and diabetes : A secondary analysis of a randomized clinical trial. | 2025 | Details |
A00201 | 39806375 | Cardiovasc Diabetol | Echocardiographic phenotypes of diabetic myocardial disorder: evolution over 15 months follow-up in the ARISE-HF trial. | 2025 | Details |
A00202 | 39816051 | Narra J | Effects of cholecalciferol supplementation on depressive symptoms, C-peptide, serotonin, and neurotrophin-3 in type 2 diabetes mellitus: A double-blind, randomized, placebo-controlled trial. | 2025 | Details |
A00204 | 39873191 | Gut Microbes | Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet. | 2025 | Details |
A00205 | 39903475 | Ann Med | An overview of downhill esophageal varices: a challenge for medical practice. | 2025 | Details |
A00207 | 39957366 | Ren Fail | Public interest in chronic kidney disease and dialysis: a 20-year data analysis. | 2025 | Details |